Coronavirus: Novavax says COVID-19 vaccine 90% effective in clinical trial

In the trial, researchers recorded 77 coronavirus cases, according to the release.

“Serious and severe adverse events were low in number and balanced between vaccine and placebo groups.

By using this website, you accept the terms of our Visitor Agreement and Privacy Policy, and understand your options regarding Ad Choices.

…Read the full story